C5R-59572-81255
4 vaccinations
18 coded responses
27 check-ins
18 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 949 / CA
- Registered
- 2021-10-24
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Dose 1 — Pfizer-BioNTech
-
2021-04-07
Dose 2 — Pfizer-BioNTech
-
2021-10-23
Dose 3 — Pfizer-BioNTech
-
2021-10-24
Registered in v-safe
-
2021-10-24
Survey response — days 1–6 daily, dose 3MedDRA: Injection site pain — Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Arm pain at site of injectionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-25
Survey response — days 1–6 daily, dose 3MedDRA: Mental fatigue — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Mental fatigueMedDRA releases: 2024-11 · check-in free text available
-
2021-10-26
Survey response — days 1–6 daily, dose 3MedDRA: Insomnia, Pain — Feeling: Fair · Site: Pain, Redness, Swelling · Be unable to do your normal daily activitiesFree text: Difficulty sleeping last night due to achinessMedDRA releases: 2024-11 · check-in free text available
-
2021-10-27
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-28
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: FairFree text: Swollen lymph node later yesterdayMedDRA releases: 2024-11 · check-in free text available
-
2021-10-29
Survey response — days 1–6 daily, dose 3MedDRA: Arthralgia, Back pain — Feeling: Fair · Site: Pain · Be unable to do your normal daily activitiesFree text: Back and hip pain during the nightMedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Health check-in — day 7, dose 3Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-11-06
Survey response — day 14, dose 3MedDRA: Urticaria — Feeling: GoodFree text: UrticariaMedDRA releases: 2024-11 · check-in free text available
- 2021-11-13
- 2021-11-20
- 2021-11-27
- 2021-12-04
- 2022-01-22
-
2022-04-13
Dose 4 — Moderna
-
2022-04-14
Survey response — days 1–6 daily, dose 4MedDRA: Brain fog — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Cognitive fuzzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-04-15
Survey response — days 1–6 daily, dose 4MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Headache, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: My angiodema flared up all over my body.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-16
Survey response — days 1–6 daily, dose 4MedDRA: Angioedema, Pre-existing disease — Feeling: Poor · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: My angiodema continues to worsen and I had had to increase my dosage of prednisone.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-17
Survey response — days 1–6 daily, dose 4MedDRA: Angioedema, Pre-existing disease, Unevaluable event — Feeling: Fair · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): I have angiodema. It flared after my booster. I am now taking high dose prednisone to control the flareup. · Healthcare visit (other): Left a message for my doctor Fri aft. Will check in tomorrow with him.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-17
Report sent to call center — days 1–6 daily, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-04-18
Survey response — days 1–6 daily, dose 4MedDRA: Angioedema — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Angiodema is responding to increased dosage of prednisone. Will see my specislist doctor on Fri.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-19
Survey response — days 1–6 daily, dose 4MedDRA: Condition aggravated, Pre-existing disease — Feeling: GoodFree text: Angiodema flareup has receded.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-20
Survey response — day 7, dose 4MedDRA: Angioedema, Inflammation, Pre-existing disease — Feeling: GoodFree text: Slight inflammation due to remaining angiodema flareupMedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Survey response — day 14, dose 4MedDRA: Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Continued hives requiring increased dose of prednisone than before the booster.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Report sent to call center — day 14, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-28
-
2022-04-28
Call successfulDoes not wish to fill out VAERS report
- 2022-05-04
-
2022-05-11
Survey response — day 28, dose 4MedDRA: Angioedema, Pre-existing disease, Scar, Vascular rupture — Feeling: Fair · Be unable to do your normal daily activitiesFree text: My angiodema flared after the booster. It has worsened in the last week. I have scars in my legs from popped blood vessels.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-18
-
2022-05-25
Survey response — day 42, dose 4MedDRA: Dermatitis, Vasculitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Skin inflammation that affected blood vessels. Received a punch biopsy for vasculitis yesterday. Waiting for results.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-15
Survey response — 3 months, dose 4MedDRA: Systemic lupus erythematosus, Unevaluable event, Urticarial vasculitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Been diagnosed with urticarial vasculitis. Being treated for Lupus. · Healthcare visit (other): Referred to dermatologist and rheumatologist at (b)(6).MedDRA releases: 2024-11 · check-in free text available
-
2022-07-15
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-07-18
-
2022-10-12
Survey response — 6 months, dose 4MedDRA: Connective tissue disorder, Dry eye, Dry mouth, Nodal arrhythmia, Supraventricular tachycardia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Diagnosis of Unspecified Connective Tissue Disorder. Increased severity of dry eyes and dry mouth. Started on Hydroxychloroquine. Arythemia Nodosum. Tachycardia (SVT).MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Pfizer-BioNTech | No |
| 2 | 2021-04-07 | Pfizer-BioNTech | No |
| 3 | 2021-10-23 | Pfizer-BioNTech | No |
| 4 | 2022-04-13 | Moderna | No |
Call center
3 call center cases
2 successful · 1 unsuccessful
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Arm pain at site of injection
Systemic reaction (other): Mental fatigue
Systemic reaction (other): Difficulty sleeping last night due to achiness
Systemic reaction (other): Swollen lymph node later yesterday
Systemic reaction (other): Back and hip pain during the night
Release 10 — day 14, dose 3
Symptoms: Urticaria
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Cognitive fuzziness
Systemic reaction (other): My angiodema flared up all over my body.
Systemic reaction (other): My angiodema continues to worsen and I had had to increase my dosage of prednisone.
Systemic reaction (other): I have angiodema. It flared after my booster. I am now taking high dose prednisone to control the flareup.
Healthcare visit (other): Left a message for my doctor Fri aft. Will check in tomorrow with him.
Systemic reaction (other): Angiodema is responding to increased dosage of prednisone. Will see my specislist doctor on Fri.
Systemic reaction (other): Angiodema flareup has receded.
Release 11 — day 7, dose 4
Systemic reaction (other): Slight inflammation due to remaining angiodema flareup
Release 11 — day 14, dose 4
Symptoms: Continued hives requiring increased dose of prednisone than before the booster.
Release 11 — day 28, dose 4
Symptoms: My angiodema flared after the booster. It has worsened in the last week. I have scars in my legs from popped blood vessels.
Release 11 — day 42, dose 4
Symptoms: Skin inflammation that affected blood vessels. Received a punch biopsy for vasculitis yesterday. Waiting for results.
Release 12 — 3 months, dose 4
Symptoms: Been diagnosed with urticarial vasculitis. Being treated for Lupus.
Healthcare visit (other): Referred to dermatologist and rheumatologist at (b)(6).
redacted (b)(6)
Release 12 — 6 months, dose 4
Symptoms: Diagnosis of Unspecified Connective Tissue Disorder. Increased severity of dry eyes and dry mouth. Started on Hydroxychloroquine. Arythemia Nodosum. Tachycardia (SVT).
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Angioedema | · | · | ✓ |
| SD | Connective tissue disorder | · | · | ✓ |
| SD | Dermatitis | · | · | ✓ |
| SD | Dry eye | · | · | ✓ |
| SD | Dry mouth | · | · | ✓ |
| SD | Nodal arrhythmia | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Scar | · | · | ✓ |
| SD | Supraventricular tachycardia | · | · | ✓ |
| SD | Systemic lupus erythematosus | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SD | Urticarial vasculitis | · | · | ✓ |
| SD | Vascular rupture | · | · | ✓ |
| SD | Vasculitis | · | · | ✓ |
| SRO | Angioedema | · | · | ✓ |
| SRO | Arthralgia | · | · | ✓ |
| SRO | Back pain | · | · | ✓ |
| SRO | Brain fog | · | · | ✓ |
| SRO | Condition aggravated | · | · | ✓ |
| SRO | Inflammation | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Mental fatigue | · | · | ✓ |
| SRO | Pain | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release